Small Molecules
31 October 2014
Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal “Headache”31 October 2014
Xcovery Presents Phase 1 Results of X-396 in ALK positive NSCLC at the 2014 Multidisciplinary Symposium in Thoracic Oncology30 October 2014
ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA30 October 2014
AnaMar AB Reports Top-Line Results from Exploratory Phase 2a Study of AMAP102 and Provides Corporate Update30 October 2014
Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia30 October 2014
GW Pharmaceuticals Commences Phase 2/3 Clinical Trial of Epidiolex(R) as a Potential Treatment for Epilepsy in Dravet Syndrome29 October 2014
Cara Therapeutics Announces Positive Results From Human Abuse Liability Trial of Peripheral Opioid for Acute Pain, I.V. CR84529 October 2014
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis28 October 2014
FORUM Pharmaceuticals Inc. Presents FRM-0334 Studies at 9th International Conference on Frontotemporal Dementias28 October 2014
Moberg Pharma: First Patient Included in Phase ll Study of BUPI, a Novel Topical Formulation for Treatment of Oral Pain27 October 2014
Alchemia Announces Phase III Trial Results for HA-Irinotecan in Metastatic Colorectal Cancer24 October 2014
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in EuropeNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports